Systematic review of allelic exchange experiments aimed at identifying mutations that confer drug resistance in Mycobacterium tuberculosis
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Systematic review of allelic exchange experiments aimed at identifying mutations that confer drug resistance in Mycobacterium tuberculosis
Authors
Keywords
-
Journal
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Volume 69, Issue 2, Pages 331-342
Publisher
Oxford University Press (OUP)
Online
2013-09-21
DOI
10.1093/jac/dkt358
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Rifampicin-resistant and rifabutin-susceptible Mycobacterium tuberculosis strains: a breakpoint artefact?
- (2013) T. Schon et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Extending the Definition of the GyrB Quinolone Resistance-Determining Region in Mycobacterium tuberculosis DNA Gyrase for Assessing Fluoroquinolone Resistance in M. tuberculosis
- (2012) Alix Pantel et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Xpert® MTB/RIF assay evaluation in South Korea, a country with an intermediate tuberculosis burden
- (2012) S. Y. Kim et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- A systematic review of gyrase mutations associated with fluoroquinolone-resistant Mycobacterium tuberculosis and a proposed gyrase numbering system
- (2012) Fernanda Maruri et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- New Insights into Fluoroquinolone Resistance in Mycobacterium tuberculosis: Functional Genetic Analysis of gyrA and gyrB Mutations
- (2012) Seidu Malik et al. PLoS One
- Characterization of rifampin-resistant isolates of Mycobacterium tuberculosis from Sichuan in China
- (2012) Ke Tang et al. TUBERCULOSIS
- Current Prospects for the Fluoroquinolones as First-Line Tuberculosis Therapy
- (2011) Howard Takiff et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Impact of the E540V Amino Acid Substitution in GyrB ofMycobacterium tuberculosison Quinolone Resistance
- (2011) Hyun Kim et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mycobacterium tuberculosis embBCodon 306 Mutations Confer Moderately Increased Resistance to Ethambutol In Vitro and In Vivo
- (2011) Claudia Plinke et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- DNA Gyrase Inhibition Assays Are Necessary To Demonstrate Fluoroquinolone Resistance Secondary togyrBMutations in Mycobacterium tuberculosis
- (2011) Alix Pantel et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The ins and outs of Mycobacterium tuberculosis drug susceptibility testing
- (2011) E.C. Böttger CLINICAL MICROBIOLOGY AND INFECTION
- Evaluation of the GenoType® MTBDRsl assay for susceptibility testing of second-line anti-tuberculosis drugs
- (2011) H. M. Said et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Mutations outside the rifampicin resistance-determining region associated with rifampicin resistance in Mycobacterium tuberculosis
- (2011) Gilman Kit Hang Siu et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Performance Assessment of the GenoType MTBDRslTest and DNA Sequencing for Detection of Second-Line and Ethambutol Drug Resistance among Patients Infected with Multidrug-Resistant Mycobacterium tuberculosis
- (2011) Wei-Lun Huang et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Downregulation of katG expression is associated with isoniazid resistance in Mycobacterium tuberculosis
- (2011) Hiroki Ando et al. MOLECULAR MICROBIOLOGY
- Rifamycin inhibition of WT and Rif-resistant Mycobacterium tuberculosis and Escherichia coli RNA polymerases in vitro
- (2011) Sumandeep K. Gill et al. TUBERCULOSIS
- GeneXpert—A Game-Changer for Tuberculosis Control?
- (2011) Carlton A. Evans PLOS MEDICINE
- Treatment Outcomes among Patients with Extensively Drug‐Resistant Tuberculosis: Systematic Review and Meta‐Analysis
- (2010) Karen R. Jacobson et al. CLINICAL INFECTIOUS DISEASES
- Detection by GenoType MTBDRsl Test of Complex Mechanisms of Resistance to Second-Line Drugs and Ethambutol in Multidrug-Resistant Mycobacterium tuberculosis Complex Isolates
- (2010) F. Brossier et al. JOURNAL OF CLINICAL MICROBIOLOGY
- The Arabinosyltransferase EmbC Is Inhibited by Ethambutol in Mycobacterium tuberculosis
- (2009) R. Goude et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Allelic Exchange and Mutant Selection Demonstrate that Common Clinical embCAB Gene Mutations Only Modestly Increase Resistance to Ethambutol in Mycobacterium tuberculosis
- (2009) H. Safi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Genetic evaluation of relationship between mutations in rpoB and resistance of Mycobacterium tuberculosis to rifampin
- (2009) Anna Zaczek et al. BMC MICROBIOLOGY
- Resistant mutants of Mycobacterium tuberculosis selected in vitro do not reflect the in vivo mechanism of isoniazid resistance
- (2009) Indra L. Bergval et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Mycobacterium tuberculosis Strains with Highly Discordant Rifampin Susceptibility Test Results
- (2009) A. Van Deun et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Feasibility of the GenoType MTBDRsl Assay for Fluoroquinolone, Amikacin-Capreomycin, and Ethambutol Resistance Testing of Mycobacterium tuberculosis Strains and Clinical Specimens
- (2009) D. Hillemann et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Standardized Treatment of Active Tuberculosis in Patients with Previous Treatment and/or with Mono-resistance to Isoniazid: A Systematic Review and Meta-analysis
- (2009) Dick Menzies et al. PLOS MEDICINE
- Tuberculosis Drug Resistance Mutation Database
- (2009) Andreas Sandgren et al. PLOS MEDICINE
- Mutagenesis in the 3 4 GyrA Helix and in the Toprim Domain of GyrB Refines the Contribution of Mycobacterium tuberculosis DNA Gyrase to Intrinsic Resistance to Quinolones
- (2008) S. Matrat et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mutations at embB Codon 306 Are an Important Molecular Indicator of Ethambutol Resistance in Mycobacterium tuberculosis
- (2008) A. M. Starks et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Convergent Evolutionary Analysis Identifies Significant Mutations in Drug Resistance Targets of Mycobacterium tuberculosis
- (2008) M. H. Hazbon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Transfer of embB Codon 306 Mutations into Clinical Mycobacterium tuberculosis Strains Alters Susceptibility to Ethambutol, Isoniazid, and Rifampin
- (2008) H. Safi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparison of gyrA gene mutations between laboratory-selected ofloxacin-resistant Mycobacterium tuberculosis strains and clinical isolates
- (2008) Zhaogang Sun et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- emb nucleotide polymorphisms and the role of embB306 mutations in Mycobacterium tuberculosis resistance to ethambutol
- (2008) Shashikant Srivastava et al. INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started